Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 2018

View Archived Issues

Fusion of neoplastic cells with macrophages confers metastatic growth advantages and poor prognosis

Bispecific-anchored cytotoxicity activator antibody induces ovarian cancer cell death

Ability to analyze old samples leads to new ovarian cancer biomarker

Atlantic Healthcare reports phase I data on oral alicaforsen for Crohn's disease

Sanwa Kagaku Kenkyusho obtains approval for Metoana in Japan

FDA gives favorable response to pre-IND meeting package for phase II study of CSTD002-NK

NO signals quorum for macrophages

Combination antibodies suppress HIV and resistance

Exhausted T cells play role in fibrosis

Cell cycle kinase affects platelet cytoskeleton

Korea Research Institute of Chemical Technology and collaborators patent GPR119 agonists

Sunshine Lake Pharma describes new SLC22A12 and xanthine oxidase inhibitors

Lytix Biopharma initiates recruitment in the sarcoma study of LTX-315

New PRMT5 inhibitors discovered at Prelude Therapeutics

FDA approves IND application to initiate clinical testing of TT-00420 in TNBC

Eli Lilly presents nuclear receptor ROR-gammaT inverse agonists

Achillion Pharmaceuticals identifies complement factor D inhibitors

BIT225-009 phase II study demonstrates significant immunological benefits in HIV-infected patients

FDA approves Fycompa for partial-onset seizures in pediatric patients

Promising outcome of IDMC interim review for phase II study of F-351 for liver fibrosis

FDA approves Libtayo for cutaneous squamous cell carcinoma

Innovent cleared to conduct clinical trials of IBI-188

FDA grants accelerated approval to Arikayce for MAC lung disease

AvroBio updates gene therapy programs in Gaucher's disease and Fabry disease

VEGF-D, MMP-2 and MMP-7 biomarkers in lymphangioleiomyomatosis and tuberous sclerosis complex

CaSR found as a novel therapeutic target for pulmonary fibrosis

NEAT1 found as new therapeutic target for occlusive vascular diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.